Yatırımcı.AI

USUSDOct 30, 03:00

Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc IOVA

USD 8.48−1.08 (−11.30%)

About TRY 423.74 · converted at USD/TRY 49.9695, November 2, 2026, 19:45

Previous close
9.56
Market cap
USD 3.8B

Key Data

USD 3.8B
USD −0.69
Previous close
9.56
Avg. volume (200d)
16M
Sector
Healthcare
Industry
Biotechnology

Technical Signals

Technical signals

Only our Plus members can access this area.

AI Models

AI models

Only our Plus members can access this area.

About Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc (IOVA) last traded at 8.48 USD on the US stock market, a daily move of −11.30%. Converted at the USD/TRY rate of 49.9695 as of November 2, 2026, 19:45, this price equals about TRY 423.74; the conversion is for information only and the rate a broker applies may differ. Market capitalization is 3.8B USD, earnings per share −0.69 USD, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Biotechnology industry.

Frequently Asked Questions

Iovance Biotherapeutics Inc (IOVA) last traded at 8.48 USD, a daily change of −11.30%. Prices are delayed by at least 15 minutes.

The last price of Iovance Biotherapeutics Inc (IOVA) is USD 8.48. Converted at the USD/TRY rate of 49.9695 as of November 2, 2026, 19:45, that is about TRY 423.74. The conversion is for information only; trades use the exchange rate and fees your broker applies.

US stocks such as Iovance Biotherapeutics Inc (IOVA) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.

IOVA trades at a price-to-earnings ratio of —, with earnings per share of −0.69 USD and a market capitalization of 3.8B USD. Ratios use the latest reported results and the current price.

The 52-week range for IOVA cannot be calculated right now.

The current dividend yield of IOVA is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.

Iovance Biotherapeutics Inc (IOVA) is listed on the US stock market; its sector is Healthcare and its industry is Biotechnology.

Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.